Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. EKF Diagnostics Holdings's shares outstanding for the quarter that ended in Dec. 2025 was 433.83 Mil.
EKF Diagnostics Holdings's quarterly shares outstanding
declined
from Jun. 2025 (449.09 Mil) to Dec. 2025 (433.83 Mil).
It means EKF Diagnostics Holdingsbought back shares from Jun. 2025 to Dec. 2025 .
EKF Diagnostics Holdings's annual shares outstanding
declined
from Dec. 2024 (453.73 Mil) to Dec. 2025 (433.83 Mil).
It means EKF Diagnostics Holdingsbought back shares from Dec. 2024 to Dec. 2025 .
A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.
Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.
Be Aware
Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.
Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.
If net earnings is less than 10%, likely to be in a highly competitive business.
EKF Diagnostics Holdings Shares Outstanding (EOP) Related Terms
EKF Diagnostics Holdings Shares Outstanding (EOP) Historical Data
* Premium members only.
The historical data trend for EKF Diagnostics Holdings's Shares Outstanding (EOP) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LSE:EKF vs ABT, SYK, MDT: Shares Outstanding (EOP) Comparison
For the Medical Devices subindustry, EKF Diagnostics Holdings's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EKF Diagnostics Holdings Shares Outstanding (EOP) vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, EKF Diagnostics Holdings's Shares Outstanding (EOP) distribution charts can be found below:
* The bar in red indicates where EKF Diagnostics Holdings's Shares Outstanding (EOP) falls into.
Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.
Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.
What does a Shares Outstanding (EOP) of 433.83 Mil mean?
EKF Diagnostics Holdings (LSE:EKF) has a Shares Outstanding (EOP) of 433.83 Mil as of Dec. 2025. The total shares a company has outstanding, at period-end. View historical data on EKF Diagnostics Holdings and its competitors.
Is EKF Diagnostics Holdings' Shares Outstanding (EOP) too high?
EKF Diagnostics Holdings' current Shares Outstanding (EOP) is 433.83 Mil. Overall, EKF Diagnostics Holdings has a GF Score™ of 52/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does EKF Diagnostics Holdings' Shares Outstanding (EOP) compare to ABT and SYK?
EKF Diagnostics Holdings' Shares Outstanding (EOP) of 433.83 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Medical Devices & Instruments company?
A good Shares Outstanding (EOP) depends on the Medical Devices & Instruments industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on EKF Diagnostics Holdings and its competitors. EKF Diagnostics Holdings's current Shares Outstanding (EOP) is 433.83 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EKF Diagnostics Holdings stock overvalued right now?
Based on GuruFocus' analysis, EKF Diagnostics Holdings (LSE:EKF) is currently considered Fairly Valued. The stock's GF Value™ is £0.28, compared to a current price of £0.26 — trading 7.3% below its estimated fair value. The current Shares Outstanding (EOP) is 433.83 Mil. EKF Diagnostics Holdings' overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For EKF Diagnostics Holdings (LSE:EKF), the current Shares Outstanding (EOP) is 433.83 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EKF Diagnostics Holdings (LSE:EKF) Overvalued in 2026?
Based on GuruFocus' analysis, EKF Diagnostics Holdings stock appears to be undervalued.
The current stock price of £0.26 is trading 7.3% below its estimated GF Value™ of £0.28.
GuruFocus considers EKF Diagnostics Holdings to be Fairly Valued.
Key valuation signals for LSE:EKF:
Shares Outstanding (EOP): 433.83 Mil
GF Value™: £0.28 vs. price of £0.26 (7.3% below fair value)
No single metric tells the full story. See the LSE:EKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EKF Diagnostics Holdings PLC is engaged in development, manufacture and supply of products and services into the in-vitro diagnostic (IVD) market place. The Group has presence in the UK, USA, Germany, and Russia, and sells throughout the world including Europe, the Middle East, the Americas, Asia, and Africa. It derive their revenue from the manufacture and sale of medical diagnostic equipment and reagents. Other services include the servicing and distribution of third party company products under separate distribution agreements.
52GF Score
Get the complete analysis for LSE:EKF
Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:EKF has been successfully added to your 
